Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients

Fig. 4

Performance evaluation of the 23-gene panel against commercially used gene panels. a, b The Pearson correlation coefficient of 23-gene TMB with F1CDx-TMB (a) and MSK-TMB (b). c, d The Pearson correlation coefficient of WES-TMB with F1CDx-TMB (c) and incorporated panel of 405 cancer-associated genes in F1CDx with 23-gene panel (F1CDx + 23 gene-TMB) (d). e, f The Pearson correlation coefficient of WES-TMB with MSK-TMB (e) and incorporated panel of 414 cancer-associated genes in MSK-IMPACT with 23 gene-panel (MSK + 23 gene-TMB) (f)

Back to article page